Why do patients with colon cancer develop anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Why Colon Cancer Causes Anemia

Patients with colon cancer develop anemia through two primary mechanisms: chronic blood loss from the tumor causing absolute iron deficiency, and cancer-related inflammation triggering functional iron deficiency via hepcidin upregulation that blocks iron utilization.

Primary Mechanisms

Chronic Blood Loss (Absolute Iron Deficiency)

  • Tumor bleeding is the most direct cause, particularly in right-sided (cecum, ascending, transverse) colon cancers where occult blood loss depletes iron stores over time 1, 2.
  • This leads to microcytic anemia, which is most commonly associated with proximal colon tumor locations 3, 4.
  • Absolute iron deficiency occurs when ferritin levels drop below 100 ng/mL, reflecting truly depleted iron stores 1.

Inflammatory Iron Sequestration (Functional Iron Deficiency)

  • Cancer-induced inflammation releases proinflammatory cytokines that upregulate hepcidin, the master regulator of iron homeostasis 1.
  • Elevated hepcidin causes internalization of ferroportin (the transmembrane iron export channel), trapping iron inside enterocytes and macrophages and preventing its release into circulation 1.
  • This creates functional iron deficiency where iron stores appear adequate (ferritin may be normal or elevated), but iron cannot be mobilized for red blood cell production 1, 2.
  • Normocytic anemia is the most frequent type in colorectal cancer (43% of patients), and correlates strongly with systemic inflammation markers including elevated C-reactive protein, IL-8, and modified Glasgow Prognostic Score 3.

Additional Contributing Factors

Tumor-Related Factors

  • Larger tumor size and deeper invasion beyond the muscle layer correlate with higher anemia rates 4.
  • Marrow infiltration by tumor can directly suppress red blood cell production, though this is less common in colorectal cancer 2.

Treatment-Related Causes

  • Chemotherapy-induced myelosuppression further worsens anemia 2.
  • Surgical blood loss and frequent phlebotomy for laboratory testing contribute to red blood cell depletion 2.

Clinical Significance

Preoperative anemia occurs in 20-44% of colorectal cancer patients and independently predicts worse overall survival and disease-free survival 5.

Key Pitfalls to Avoid

  • Do not assume all anemia in colon cancer is simply from bleeding—the inflammatory component (functional iron deficiency) is equally important and requires different treatment (intravenous iron rather than oral supplementation) 1.
  • Oral iron is poorly absorbed in the inflammatory state due to hepcidin blockade and should not be the primary treatment when C-reactive protein is elevated (>5 mg/L) 1.
  • Normocytic anemia with elevated inflammatory markers indicates functional iron deficiency requiring intravenous iron, not just transfusion 1, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.